Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions

scientific article published on 01 September 2000

Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1098-2396(20000915)37:4<298::AID-SYN7>3.0.CO;2-A
P698PubMed publication ID10891867

P2093author name stringMehta A
Chesselet MF
Thermos K
P2860cites workA role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesiaQ71323714
Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primatesQ71438213
Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring ratsQ71539062
Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic innervation to the subthalamic nucleus in the ratQ72277088
Tardive dyskinesiaQ72578948
Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in ratsQ72690516
Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatmentQ72691758
Prognosis in hemiballismusQ74502515
The thyrotrophin-releasing hormone analogue MK771 induces tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonistsQ77329251
Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistryQ28257992
Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's diseaseQ28329967
Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacyQ28334235
D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeysQ28371745
The functional anatomy of basal ganglia disordersQ29617461
Primate models of movement disorders of basal ganglia originQ29618489
A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosetsQ34245559
Ballism and the subthalamic nucleus hypothalamicus; corpus luysi) review of the literature and study of 30 cases.Q37298378
Reversal of experimental parkinsonism by lesions of the subthalamic nucleusQ41241320
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.Q42539523
Neurotoxicity induced by the D-1 agonist SKF 38393 following microinjection into rat brainQ43504754
The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptorsQ44319553
The current model of basal ganglia organization under scrutinyQ45295875
Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmissionQ48111942
The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolismQ48149918
Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos studyQ48161168
Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesionsQ48178832
Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleusQ48179313
Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiographyQ48189173
Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.Q48266857
Blockade of subthalamic dopamine D1 receptors elicits akinesia in ratsQ48295948
Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone bindingQ48311680
Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleusQ48334169
Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's diseaseQ48373524
Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's diseaseQ48477508
Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresisQ48488722
Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat.Q48797018
Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the rat.Q48877841
The dopamine receptor adenylate cyclase complex: evidence for post recognition site involvement for the development of supersensitivityQ49057979
Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administrationQ69373474
Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brainQ70800697
P433issue4
P921main subjectsubthalamic nucleusQ2270424
P304page(s)298-307
P577publication date2000-09-01
P1433published inSynapseQ7662025
P1476titleIncreased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions
P478volume37

Reverse relations

cites work (P2860)
Q30484170Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease
Q44205707Compromised peripheral immunity of mice injected intrastriatally with six-hydroxydopamine
Q34349190D1 dopamine receptors
Q42436820D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance.
Q82029300Dopamine receptor pharmacology
Q42435952Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology
Q34330022Extrastriatal dopaminergic circuits of the Basal Ganglia
Q43553273Increased m-CPP-induced oral dyskinesia after lesion of serotonergic neurons
Q33633995Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease.
Q41743040Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats.

Search more.